Diabetes Drug Funding Changes Call for Greater Equity

Health experts are advocating for a more equitable approach to diabetes drug funding aimed at Māori and Pasifika communities. They claim that Health NZ is hindering necessary changes in treatment funding.

Cardiac scientists highlight the urgent need for changes in how diabetes treatments are funded, focusing on the needs of Māori and Pasifika populations. They argue that existing obstacles from Health NZ could limit access to critical medications for these communities.

These specialists emphasise that addressing disparities in health outcomes is essential. Current funding models are seen as inadequate for the unique challenges faced by Māori and Pasifika, who are disproportionately affected by diabetes.

Originally reported by RNZ New Zealand Headlines.

Part of the Vector Group network

Te Puke Today is a news feeder for the Vector Group Charitable Trust — kai resilience, regional directory, and tools for sustainable communities.

Kai Resilience → Kiwifruit Capital → Vector Group →